Keratoconus Treatment

Understanding Corneal Cross-Linking (CXL)

Introduction:

• Corneal cross-linking (CXL) is a minimally invasive procedure used to treat keratoconus and other corneal ectatic disorders.
• Dr. Seema Behl, an expert in ophthalmology, often recommends this procedure to her patients with progressive keratoconus.

Procedure Overview:

• Riboflavin (vitamin B2) eye drops are applied to the cornea.
• The cornea is then exposed to ultraviolet (UV) light.
• This combination stimulates the formation of additional cross-links between collagen fibers in the cornea, strengthening its structure.

Aims of the Procedure:

• Halting the progression of keratoconus by increasing the biomechanical stability of the cornea.
• Preventing further thinning and bulging of the cornea, characteristic features of keratoconus.
• Note: While it does not reverse existing damage, CXL can help prevent further deterioration and preserve vision.

Procedure Details:

• Typically performed as an outpatient procedure, taking about an hour.
• Patients may experience some discomfort or sensitivity in the treated eye post-procedure.
• Symptoms usually resolve within a few days to weeks.
• Full effects may take several months to manifest.
• Some patients may require additional treatments or adjustments to their vision correction afterward.

Conclusion: